Plasma neutrophil gelatinase-associated lipocalin levels and risk of future incident venous thromboembolism
Journal of Thrombosis and Haemostasis · 2026-10
DOI: 10.1016/j.jtha.2026.10.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Thrombosis and Haemostasis, 2026-10. Verfasst von Nikolai Hagensen Eide und 5 weiteren Autor:innen. Beteiligte Einrichtung: Thrombosis Research Group (TREC), Department of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø, Norway. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stiftelsen Kristian Gerhard Jebsen.
Themen: Thromboseprophylaxe
Abstract (Originalsprache)
BACKGROUND: Although neutrophils are suggested to play a role in the pathogenesis of venous thromboembolism (VTE), no study has investigated whether neutrophil gelatinase-associated lipocalin (NGAL), a marker of neutrophil activation, is associated with future VTE risk in the general population. OBJECTIVE: To investigate the association between plasma NGAL levels and the risk of future VTE. METHODS: Plasma NGAL levels were measured in 416 VTE cases and 848 age- and sex-matched controls in a nested case-control study derived from the Tromsø study cohort (1994-2007). Logistic regression models were used to estimate odds ratios (ORs) with 95% CIs for VTE according to quartiles of plasma NGAL, adjusted for age, sex, body mass index, arterial cardiovascular disease, cancer, and C-reactive protein. Separate analyses with follow-up restricted to the first 2 and 5 years after cohort inclusion were conducted to investigate potential short-term associations. RESULTS: We found no association between NGAL levels and risk of future VTE when analyzing the entire study period (OR for highest vs lowest quartile of NGAL: 1.02, 95% CI, 0.70-1.51). However, when follow-up was restricted to 2 years, higher NGAL levels were associated with increased risk of future VTE (OR, 3.87; 95% CI, 1.15-13.03). The association was attenuated when follow-up was extended to 5 years (OR, 1.51; 95% CI, 0.82-2.80). CONCLUSION: Higher plasma NGAL levels were associated with a transiently increased risk of future VTE.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Thrombosis Research Group (TREC), Department of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø, Norway.
- Thrombosis Research Group (TREC), Department of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø, Norway; Thrombosis Research Center (TREC), Division of Internal Medicine, University Hospital of North No…
- Thrombosis Research Group (TREC), Department of Clinical Medicine, UiT - The Arctic University of Norway, Tromsø, Norway; Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway;…
- Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Section of Clinical Immunology and…
Förderung
- Stiftelsen Kristian Gerhard Jebsen
Zitieren
APA
Eide, N. H., Morelli, V. M., Ueland, T., Aukrust, P., Brækkan, S. K., & Hansen, J. B. (2026). Plasma neutrophil gelatinase-associated lipocalin levels and risk of future incident venous thromboembolism. Journal of Thrombosis and Haemostasis. https://doi.org/10.1016/j.jtha.2026.10.005
Vancouver
Eide NH, Morelli VM, Ueland T, Aukrust P, Brækkan SK, Hansen JB. Plasma neutrophil gelatinase-associated lipocalin levels and risk of future incident venous thromboembolism. Journal of Thrombosis and Haemostasis. 2026. doi:10.1016/j.jtha.2026.10.005
BibTeX
@article{Eide2026,
author = {Eide, Nikolai Hagensen and Morelli, Vania Maris and Ueland, Thor and Aukrust, Pål and Brækkan, Sigrid Kufaas and Hansen, John-Bjarne},
title = {Plasma neutrophil gelatinase-associated lipocalin levels and risk of future incident venous thromboembolism},
journal = {Journal of Thrombosis and Haemostasis},
year = {2026},
doi = {10.1016/j.jtha.2026.10.005}
}
EUVIMED